Latest analyst takes
ValuetainmentBEARMRNA appears to be preparing next-generation mRNA shots related to this “antivirus” threat (citing work from 2024 with Korea University), which he frames as evidence the vaccine program is implicitly tied to ongoing pathogen risk.3d ago
Investors UndergroundBEARMRNA looks vulnerable after earnings because the updated story still relies on a different COVID-vaccine approach that isn’t convincing enough to prevent a breakdown below key levels.7d ago"MRNA appears to be preparing next-generation mRNA shots related to this “antivirus” threat (citing work from 2024 with Korea University), which he frames as evidence the vaccine program is implicitly tied to ongoing pathogen risk."
"MRNA looks vulnerable after earnings because the updated story still relies on a different COVID-vaccine approach that isn’t convincing enough to prevent a breakdown below key levels."